Symbol
DNTH on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned
2,139,635 shares
Security Ownership %
4.9%
Shares, Excluding Options vs Price
Value, Excluding Options

Fairmount Funds Management LLC ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH)

25 Nov 2025 - Fairmount Funds Management LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,139,635 shares of Dianthus Therapeutics, Inc. /DE/ Common Stock, par value $0.001 per share (DNTH). This represents 4.9% ownership of the company. In their previous filing dated 15 Sep 2025, Fairmount Funds Management LLC had reported owning 4,052,052 shares, indicating a decrease of +47%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.